blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2504002

EP2504002 - TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  16.09.2022
Database last updated on 09.07.2024
FormerThe patent has been granted
Status updated on  06.09.2019
FormerGrant of patent is intended
Status updated on  06.05.2019
FormerExamination is in progress
Status updated on  17.04.2019
FormerGrant of patent is intended
Status updated on  03.12.2018
FormerExamination is in progress
Status updated on  26.05.2017
Most recent event   Tooltip16.09.2022Revocation of patentpublished on 19.10.2022  [2022/42]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2019/41]
Former [2012/40]For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / DUGI, Klaus
Boehringer Ingelheim GmbH
Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
02 / GRAEFE-MODY, Eva, Ulrike
Boehringer Ingelheim GmbH
CorporatePatents
Binger Str. 173
55216 Ingelheim am Rhein / DE
03 / MARK, Michael
Boehringer Ingelheim GmbH
Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
04 / WOERLE, Hans-Juergen
Boehringer Ingelheim GmbH
Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
05 / ZIMDAHL-GELLING, Heike
Boehringer Ingelheim GmbH
Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
 [2012/40]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2012/40]Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date10785054.726.11.2010
[2019/41]
WO2010EP68349
Priority number, dateEP2009017741827.11.2009         Original published format: EP 09177418
EP2010016671421.06.2010         Original published format: EP 10166714
[2012/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011064352
Date:03.06.2011
Language:EN
[2011/22]
Type: A1 Application with search report 
No.:EP2504002
Date:03.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 03.06.2011 takes the place of the publication of the European patent application.
[2012/40]
Type: B1 Patent specification 
No.:EP2504002
Date:09.10.2019
Language:EN
[2019/41]
Search report(s)International search report - published on:EP03.06.2011
ClassificationIPC:A61K31/155, A61K31/44, A61K31/519, A61K45/06, A61P3/10
[2018/47]
CPC:
A61K31/522 (EP,CN,EA,KR,US); A61K45/06 (EP,CN,EA,KR,US); A61K31/155 (EP,CN,EA,KR,US);
A61K31/426 (KR); A61K31/44 (EP,EA,US); A61K31/4439 (EP,CN,EA,KR,US);
A61K31/4985 (EP,EA,US); A61K31/513 (EP,EA,US); A61K31/519 (EP,EA,US);
A61K31/64 (KR); A61K38/26 (EP,EA,US); A61K38/28 (EP,EA,US);
A61P1/16 (KR); A61P1/18 (KR); A61P3/04 (KR);
A61P3/10 (EP,EA,KR); A61K2300/00 (EA,KR) (-)
C-Set:
A61K31/155, A61K2300/00 (EP,CN,US);
A61K31/4439, A61K2300/00 (CN);
A61K31/44, A61K2300/00 (US,EP);
A61K31/519, A61K2300/00 (US,EP);
A61K31/522, A61K2300/00 (CN)
(-)
Former IPC [2012/40]A61K31/155, A61K31/44, A61K31/519, A61K45/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/40]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BEHANDLUNG VON GENOTYPISIERTEN DIABETES-PATIENTEN MIT DPP-IV-HEMMERN WIE ETWA LINAGLIPTIN[2012/40]
English:TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN[2012/40]
French:TRAITEMENT DE PATIENTS DIABÉTIQUES GÉNOTYPÉS PAR DES INHIBITEURS DE DPP-IV TELS QUE LA LINAGLIPTINE[2012/40]
Entry into regional phase27.06.2012National basic fee paid 
27.06.2012Designation fee(s) paid 
27.06.2012Examination fee paid 
Examination procedure26.06.2012Amendment by applicant (claims and/or description)
27.06.2012Examination requested  [2012/40]
25.09.2013Despatch of a communication from the examining division (Time limit: M06)
30.04.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.07.2014Reply to a communication from the examining division
20.04.2015Despatch of a communication from the examining division (Time limit: M06)
30.10.2015Reply to a communication from the examining division
08.03.2016Despatch of a communication from the examining division (Time limit: M06)
16.09.2016Reply to a communication from the examining division
16.05.2017Despatch of a communication from the examining division (Time limit: M05)
25.10.2017Reply to a communication from the examining division
22.03.2018Despatch of a communication from the examining division (Time limit: M04)
30.07.2018Reply to a communication from the examining division
04.12.2018Communication of intention to grant the patent
11.04.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.04.2019Fee for grant paid
15.04.2019Fee for publishing/printing paid
14.05.2019Communication of intention to grant the patent
02.09.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19202034.5  / EP3646859
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.09.2013
Opposition(s)Opponent(s)01  03.07.2020  07.07.2020  ADMISSIBLE
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  09.07.2020  13.07.2020  ADMISSIBLE
ELKINGTON AND FIFE LLP
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 [N/P]
Former [2020/34]
Opponent(s)01  03.07.2020  07.07.2020  ADMISSIBLE
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  09.07.2020  13.07.2020  ADMISSIBLE
ELKINGTON AND FIFE LLP
Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2020/33]
Opponent(s)01  03.07.2020  07.07.2020  ADMISSIBLE
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
21.07.2020Invitation to proprietor to file observations on the notice of opposition
30.11.2020Reply of patent proprietor to notice(s) of opposition
22.03.2022Date of oral proceedings
09.05.2022Despatch of minutes of oral proceedings
09.05.2022Despatch of communication that the patent will be revoked
02.09.2022Legal effect of revocation of patent [2022/42]
Appeal following opposition19.07.2022Appeal received No.  T1788/22
19.07.2022Payment of appeal fee
02.09.2022Result of appeal procedure: appeal of the proprietor withdrawn
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.07.2014Request for further processing filed
08.07.2014Full payment received (date of receipt of payment)
Request granted
18.07.2014Decision despatched
Fees paidRenewal fee
30.11.2012Renewal fee patent year 03
02.12.2013Renewal fee patent year 04
01.12.2014Renewal fee patent year 05
30.11.2015Renewal fee patent year 06
30.11.2016Renewal fee patent year 07
30.11.2017Renewal fee patent year 08
30.11.2018Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.11.2010
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MK09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
TR09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
[2022/31]
Former [2022/26]HU26.11.2010
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
TR09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2021/34]HU26.11.2010
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2021/32]HU26.11.2010
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2021/26]AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/51]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
IE26.11.2019
LU26.11.2019
BE30.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/46]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SK09.10.2019
SM09.10.2019
IE26.11.2019
LU26.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/37]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SK09.10.2019
SM09.10.2019
LU26.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/36]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
LU26.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/35]AL09.10.2019
AT09.10.2019
CZ09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
LU26.11.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/34]AL09.10.2019
AT09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RS09.10.2019
SE09.10.2019
CH30.11.2019
LI30.11.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/32]AL09.10.2019
AT09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/25]AT09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/24]AT09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/23]AT09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
Former [2020/22]FI09.10.2019
LT09.10.2019
NL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
PT10.02.2020
Former [2020/21]NL09.10.2019
NO09.01.2020
Former [2020/20]NL09.10.2019
Cited inInternational search[Y]WO2006137085  (DECODE GENETICS EHF [IS], et al);
 [XY]WO2008093882  (TAKEDA PHARMACEUTICAL [JP], et al);
 [XY]WO2009121945  (BOEHRINGER INGELHEIM INT [DE], et al);
ExaminationUS2006286588
by applicantUS5093330
 EP0564409
 WO9835958
 WO0034241
 US6166063
 WO0168603
 WO0214271
 US6395767
 WO02068420
 WO03004498
 WO03037327
 WO2004005281
 US6699871
 WO2004018467
 WO2004018468
 WO2004018469
 WO2004041820
 WO2004046148
 WO2004050658
 WO2004052850
 WO2004067509
 WO2004111051
 WO2005000848
 WO2005003135
 WO2005047297
 WO2005051950
 WO2005058901
 WO2005063750
 WO2005067976
 WO2005075421
 WO2005082906
 WO2005085246
 WO2005095381
 EP1586571
 WO2005097798
 WO2005106011
 US2005261271
 WO2005115982
 WO2005116014
 WO2005117841
 WO2006027204
 WO2006029769
 WO2006040625
 WO2006041976
 WO2006048427
 WO2006068163
 WO2006078593
 WO2006088129
 WO2006100181
 WO2006116157
 WO2006118127
 US2006270701
 WO2006129785
 WO2006135723
 WO2007005572
 WO2007014886
 WO2007019255
 WO2007017423
 US2007060530
 WO2007033266
 WO2007033350
 WO2007035629
 WO2007035372
 WO2007050485
 WO2007071738
 WO2007071576
 WO2007074884
 WO2007112368
 US7291618
 WO2007128721
 WO2007128724
 WO2007128761
 WO2007148185
 US2007299076
 WO2008001195
 WO2008017670
 WO2008027273
 WO2008031749
 WO2008031750
 WO2008033851
 WO2008055814
 WO2008067465
 US2008146818
 WO2008093882
 WO2008109681
 WO2008114800
 WO2008114807
 WO2008114857
 WO2008131149
 WO2008144730
 WO2009009751
 WO2009011451
 WO2009084497
 WO2009091663
 WO2009121945
 WO2009128360
 WO2009139362
OppositionWO0152825
 US2006286588
 WO2006137085
 WO2008093882
 WO2009024542
 WO2009121945
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.